BMPR1A
Reactivity: Human
WB, ELISA, IHC, IF
Host: Rabbit
Polyclonal
unconjugated
Application Notes
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (1:50-100) Western Blot (1:1000) The optimal working dilution should be determined by the end user.
Restrictions
For Research Use only
Format
Liquid
Buffer
In PBS (0.09 % sodium azide)
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing.
Waite, Eng: "BMP2 exposure results in decreased PTEN protein degradation and increased PTEN levels." in: Human molecular genetics, Vol. 12, Issue 6, pp. 679-84, (2003) (PubMed).
Zhou, Woodford-Richens, Lehtonen, Kurose, Aldred, Hampel, Launonen, Virta, Pilarski, Salovaara, Bodmer, Conrad, Dunlop, Hodgson, Iwama, Järvinen, Kellokumpu, Kim, Leggett, Markie, Mecklin, Neale et al.: "Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. ..." in: American journal of human genetics, Vol. 69, Issue 4, pp. 704-11, (2001) (PubMed).
Target
BMPR1A
(Bone Morphogenetic Protein Receptor 1A (BMPR1A))